Ibd Horizons
- Assets
- $127.4k
- Revenue
- $1.2m
- Investments
- $0.0
- Employees
- 0
- Location
- Seattle, WA
- Founding
- 06/2016
- Data as of
- 12/2022
- EIN
- 47-3378631
Organization Overview
Ibd Horizons is located in Seattle, WA. The organization was established in 2016. According to its NTEE Classification (H70) the organization is classified as: Digestive Diseases & Disorders Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Ibd Horizons is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Ibd Horizons generated $1.2m in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 26.9% each year . All expenses for the organization totaled $1.2m during the year ending 12/2022. While expenses have increased by 30.2% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
IBD HORIZONS IS FOCUSED ON PROVIDING SCIENTIFIC EDUCATION RELATED TO THE DIAGNOSIS, MANAGEMENT, AND ADVANCEMENT OF KNOWLEDGE REGARDING INFLAMMATORY BOWEL DISEASE. WE PROVIDE ACCREDITED EDUCATIONAL SYMPOSIA AND DISSEMINATE INFORMATION TO MEDICAL PROVIDERS AND RESEARCHERS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
PRODUCED ACCREDITED EDUCATIONAL SYMPOSIUM FOR CLINICIANS AND RESEARCHERS WORKING TO TREAT INFLAMMATORY BOWEL DISEASE (IBD) IN COLUMBUS, OHIO AND SEATTLE, WA. OVER 200 PROFESSIONALS ATTENDED EACH MEETING TO LEARN THE LATEST IN VARIOUS ASPECTS OF IBD TREATMENTS AND RESEARCH. THIS CONFERENCE WAS HELD ON FEB. 12, 2022 AND MARCH 5, 2022.
PRODUCED ACCREDITED EDUCATIONAL SYMPOSIUM FOR CLINICIANS AND RESEARCHERS WORKING TO TREAT INFLAMMATORY BOWL DISEASE (IBD) IN NEW ORLEANS, LA. OVER 100 PROFESSIONALS ATTENDED THIS MEETING TO LEARN THE LATEST IN VARIOUS ASPECTS OF IBD TREATMENTS AND RESEARCH. THE CONFERENCE WAS HELD ON OCTOBER 15, 2022.
SERIES OF MEETINGS, DIALOGUES, AND SMALL SEMINARS TO PROMOTE KNOWLEDGE AND RESEARCH OF CURRENT INFLAMMATORY BOWEL DISEASE (IBD) RESEARCH. PRODUCED ACCREDITED EDUCATIONAL SYMPOSIA FOR CLINICIANS AND RESEARCHERS, SPECIFICALLY TAILORED TO ADVANCED PRACTICE PROVIDERS WORKING TO TREAT INFLAMMATORY BOWEL DISEASE (IBD). OVER 150 PROFESSIONALS ATTENDED IN PERSON AND VIRTUALLY TO LEARN THE LATEST IN VARIOUS ASPECTS OF IBD TREATMENT AND RESEARCH SPECIFIC TO THE WORK OF ADVANCED PRACTICE PROVIDERS (APP).
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Scott Lee Treasurer | OfficerTrustee | 4 | $155,186 |
Ghassan Wahbeh Vice Chair | OfficerTrustee | 4 | $125,318 |
Anita Afzali Chair | OfficerTrustee | 3 | $114,333 |
Bailey Cullinan President | OfficerTrustee | 35 | $100,600 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $353,125 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $353,125 |
| Total Program Service Revenue | $873,700 |
| Investment income | $0 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $1,226,825 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $181,300 |
| Compensation of current officers, directors, key employees. | $75,000 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $0 |
| Office expenses | $0 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $0 |
| All other expenses | $0 |
| Total functional expenses | $1,248,316 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $127,435 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $127,435 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $24,221 |
| Total liabilities | $24,221 |
| Net assets without donor restrictions | $103,214 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $127,435 |